Development of Conductivity Method as an Alternative to Titration for Hydrolytic Resistance Testing Used for Evaluation of Glass Vials Used in Pharmaceutical Industry

References

1. 1.↵
   1. Scholze H.

   Glass: Nature, Structure, and Properties; Springer-Verlag: Berlin, Heidelberg, 1991.
2. 2.↵
   1. Iacocca R. G.,
   2. Toltl N.,
   3. Allgeier M.,
   4. Bustard B.,
   5. Dong X.,
   6. Foubert M.,
   7. Hofer J.,
   8. Peoples S.,
   9. Shelbourn T.

   Factors Affecting the Chemical Durability of Glass Used in the Pharmaceutical Industry. AAPS PharmSciTech 2010, 11 (3), 1340–1349.

   OpenUrlPubMed
3. 3.↵
   1. Tian L.,
   2. Dieckmann R.,
   3. Hui C.-Y.,
   4. Lin Y.-Y.,
   5. Couillard J. G.

   Effect of Water Incorporation on the Diffusion of Sodium in Type I Silica Glass. J. Non-Cryst. Solids 2001, 286 (3), 146–161.

   OpenUrl
4. 4.↵
   1. Ennis R. D.,
   2. Pritchard R.,
   3. Nakamura C.,
   4. Coulon M.,
   5. Yang T.,
   6. Visor G. C.,
   7. Lee W. A.

   Glass Vials for Small Volume Parenterals: Influence of Drug and Manufacturing Processes on Glass Delamination. Pharm. Dev. Technol. 2001, 6 (3), 393–405.

   OpenUrlPubMed
5. 5.↵
   1. Iacocca R. G.,
   2. Allgeier M.

   Corrosive Attack of Glass by a Pharmaceutical Compound. J. Mater. Sci. 2007, 42 (3), 801–811.

   OpenUrl
6. 6.↵
   1. Iacocca R. G.

   The Causes and Implications of Glass Delamination. PharmTech.com 2011, Supplement (6), November 1.
7. 7.↵
   1. Yamanaka S.,
   2. Akaji J.,
   3. Hattori M.

   Reaction of Pyrex Type Borosilicate Glass with Water in Autoclave. J. Non-Cryst. Solids 1985, 70 (2), 279–290.

   OpenUrl
8. 8.↵
   1. Bohrer D.,
   2. Bortoluzzi F.,
   3. Nascimento P. C.,
   4. Carvalho L. M.,
   5. Ramirez A. G.

   Silicate Release from Glass for Pharmaceutical Preparations. Int. J. Pharm. 2008, 355 (1–2), 174–183.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Bacon F. R.,
   2. Raggon F. C.

   Promotion of Attack on Glass and Silica by Citrate and Other Anions in Neutral Solution. J. Am. Ceram. Soc. 1959, 42 (4), 199–205.

   OpenUrl
10. 10.↵
    1. Guadagnino E.,
    2. Zuccato D.

    Delamination Propensity of Pharmaceutical Glass Containers by Accelerated Testing with Different Extraction Media. PDA J. Pharm. Sci. Technol. 2012, 66 (2), 116–125.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Jiang G.,
    2. Goss M.,
    3. Li G.,
    4. Jing W.,
    5. Shen H.,
    6. Fujimori K.,
    7. Le L.,
    8. Wong L.,
    9. Wen Z.,
    10. Nashed-Samuel Y.,
    11. Riker K.,
    12. Germansderfer A.,
    13. Tsang P.,
    14. Ricci M.

    Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations. PDA J. Pharm. Sci. Technol. 2013, 67 (4), 323–335.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    U.S. Food and Drug Administration. Safety Reports for Human Medical Products: Epoetin alfa (2010), Hyaluronidase Recombinant (2010), and Methotrexate (2013).
13. 13.↵
    Chapter 3.2.1. Glass Containers for Pharmaceutical Use. In European Pharmacopoeia, 7th ed.; Council of Europe: Strasbourg, France, 2011.
14. 14.↵
    General Chapter <660> Containers—Glass. In United States Pharmacopeia 35–National Formulary 30; U.S. Pharmacopeial Convention: Rockville, MD, 2012.
15. 15.↵
    U.S. Food and Drug Administration (FDA). Guidance for Industry—Q2B Validation of Analytical Procedures: Methodology. FDA: Rockville, MD, 1996.